A genome-engineered bioartificial implant for autoregulated anticytokine drug delivery

Authors

Yun-Rak Choi, Washington University School of Medicine in St. Louis
Kelsey H Collins, Washington University School of Medicine in St. Louis
Luke E Springer, Washington University School of Medicine in St. Louis
Lara Pferdehirt, Washington University School of Medicine in St. Louis
Alison K Ross, Washington University School of Medicine in St. Louis
Chia-Lung Wu, Washington University School of Medicine in St. Louis
Franklin T Moutos, Cytex Therapeutics Inc.
Natalia S Harasymowicz, Washington University School of Medicine in St. Louis
Jonathan M Brunger, Vanderbilt University
Christine T N Pham, Washington University School of Medicine in St. Louis
Farshid Guilak, Washington University School of Medicine in St. Louis

Journal

Science Advances

Publication Date

2021

Volume

7

Issue

36

Document Type

Open Access Publication

DOI

10.1126/sciadv.abj1414

Rights and Permissions

Choi YR, Collins KH, Springer LE, et al. A genome-engineered bioartificial implant for autoregulated anticytokine drug delivery. Sci Adv. 2021;7(36):eabj1414. doi:10.1126/sciadv.abj1414. Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S.Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Recommended Citation

Choi, Yun-Rak; Collins, Kelsey H; Springer, Luke E; Pferdehirt, Lara; Ross, Alison K; Wu, Chia-Lung; Moutos, Franklin T; Harasymowicz, Natalia S; Brunger, Jonathan M; Pham, Christine T N; and Guilak, Farshid, "A genome-engineered bioartificial implant for autoregulated anticytokine drug delivery." Science Advances. 7, 36. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10808